Alpha 2.0
Login Register
» Articles » PMID: 35362797

Re: Safety and Short-term Efficacy of Mirabegron in Children with Valve Bladder: a Pilot Study

Overview
Journal Pediatr Surg Int
Specialties General Surgery
Pediatrics
Date 2022 Apr 1
PMID 35362797
Authors
Changkai Deng
Yue Chen
Rong Dai
Affiliations
Soon will be listed here.
Abstract

Overactive bladder (OAB) is a common lower urinary tract dysfunction syndrome. A stepwise approach is a prudent choice. Urotherapy is recommended by the International Children's Continence Society (ICCS) as the first-line treatment for OAB.

Citing Articles

Re: Efficacy and safety of intradetrusor botulinum toxin injections for idiopathic overactive bladder syndrome in patients with an artificial urinary sphincter.

Deng C, Dai R World J Urol. 2022; 40(7):1893-1894.

PMID: 35486176 DOI: 10.1007/s00345-022-04020-4.

References
1.
Babu R, Chittibabu T, Chadha S . Safety and short-term efficacy of mirabegron in children with valve bladder: a pilot study. Pediatr Surg Int. 2021; 38(3):493-498. DOI: 10.1007/s00383-021-05040-8. View
2.
Austin P, Bauer S, Bower W, Chase J, Franco I, Hoebeke P . The standardization of terminology of lower urinary tract function in children and adolescents: Update report from the standardization committee of the International Children's Continence Society. Neurourol Urodyn. 2015; 35(4):471-81. DOI: 10.1002/nau.22751. View
3.
Reeves P, Irwin D, Kelleher C, Milsom I, Kopp Z, Calvert N . The current and future burden and cost of overactive bladder in five European countries. Eur Urol. 2006; 50(5):1050-7. DOI: 10.1016/j.eururo.2006.04.018. View
4.
Austin P . Stepwise treatment for overactive bladder is prudent. Can Urol Assoc J. 2017; 11(1-2Suppl1):S80. PMC: 5332243. DOI: 10.5489/cuaj.4346. View
5.
Thom M, Campigotto M, Vemulakonda V, Coplen D, Austin P . Management of lower urinary tract dysfunction: a stepwise approach. J Pediatr Urol. 2011; 8(1):20-4. DOI: 10.1016/j.jpurol.2011.01.004. View